Ronapreve
Ronapreve Products are primarily used for
Coronavirus disease (COVID-19)
About Ronapreve Products
Uses of Ronapreve Products
Casirivimab+Imdevimab is used in the treatment of Coronavirus disease (COVID-19).
Ronapreve Products side effects
Common
Side Effect of Ronapreve is Injection site reactions (pain, swelling, redness).
How Ronapreve Products work
Casirivimab + Imdevimab is a combination of two human immunoglobulins G-1 (IgG1), neutralizing monoclonal antibodies, that bind at different sites on the spike protein of SARS-CoV-2, the virus that causes COVID-19. This unique binding mechanism, developed using recombinant DNA technology, is equally effective against the existing as well as newer emerging variants and prevents the virus from attaching to the human cell receptors.
Patient Concerns about Ronapreve Products
Frequently asked questions about Ronapreve Products
Frequently asked questions about Ronapreve Products
Q. What are monoclonal antibodies? How are they relevant to Ronapreve 120mg Injection Combi Pack?
Monoclonal antibodies are specific proteins that mimic the immune system’s ability to fight against harmful microorganisms like viruses. Casirivimab and Imdevimab, the monoclonal antibodies present in Ronapreve 120mg Injection Combi Pack, help protect against the deadly SARS-CoV-2, the virus that causes COVID-19.
Q. What is a monoclonal antibody cocktail?
A monoclonal antibody cocktail is a combination of monoclonal antibodies that are available separately, but are mixed together for use as a cocktail, hence the name.
Q. How are monoclonal antibodies helpful in treating COVID-19?
SARS-CoV-2, the virus that causes COVID-19, has a spike protein on its surface that helps the virus to attach and enter the hu n body. Monoclonal antibodies are engineered to mimic this attachment with SARS-CoV-2, thereby preventing disease progression. Monoclonal antibody therapy may help in treating mild symptoms at the initial stages.
Q. When should monoclonal antibody therapy for COVID-19 be taken?
Monoclonal antibody therapy for COVID-19 should be taken after the early diagnosis of COVID-19 in patients aged 12 years or older with a bodyweight of at least 40 kg. It may also be taken by people who are at a high risk of developing a severe infection, such as those aged 60 years or above, who have comorbidities such as diabetes or hypertension, and those who are immunocompromised.
Q. Who should not take monoclonal antibodies for COVID-19?
Monoclonal antibodies for COVID-19 should not be taken by those who are hospitalized or need oxygen therapy. Additionally, it should not be taken by those under oxygen treatment due to pre-existing comorbidities that may not be associated with COVID-19. Those who are allergic to any of the two medicines in Ronapreve 120mg Injection Combi Pack or any of the other ingredients of the kit should also avoid taking this combination of monoclonal antibodies.
Q. Who is at high risk of developing severe COVID-19?
People aged above 60 years, who are obese, have comorbid conditions related to lungs, kidneys (like dialysis patients), liver, or those who have a weak immunity (like cancer patients) are at high risk of developing severe COVID-19.
Q. How is Ronapreve 120mg Injection Combi Pack used?
Ronapreve 120mg Injection Combi Pack is given as an injection into a vein (intravenously) or below the skin (subcutaneously), by a healthcare professional, in a hospital to treat mild to moderate symptoms of COVID-19. It should never be injected into a muscle (intramuscularly).
Q. I have high blood pressure and diabetes. Can I take Ronapreve 120mg Injection Combi Pack?
Yes, Ronapreve 120mg Injection Combi Pack can be taken by patients with high blood pressure or diabetes, if prescribed. As per the available data, the benefits of using monoclonal antibody therapy are more significant than the potential risks.
Products for Ronapreve
Ronapreve 120mg Injection Combi Pack
box of 1 Kit
MRP
₹119500